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collectively as the “medical expenses payment system”
and includes the provision of medical assistance for
speciﬁed intractable diseases. Because severe acute
pancreatitis has a high mortality rate, it is speciﬁed as an
intractable disease. In order to lower the mortality rate
of various diseases, including severe acute pancreatitis,
the speciﬁcation system has been adopted by the gov-
ernment. The cost of treatment for severe acute pancre-
atitis is paid in full by the government from the date the
application is made for a certiﬁcate verifying that the
patient has an intractable disease.
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Introduction
The scope of Japan’s medical security scheme is charac-
terized by the Universal Medical Care Insurance
System, which is based on the Constitution, and by the
monetary allowances provided for by this system. No
other country has a medical security system with these
characteristics. The system has made it possible for
Japan to achieve and maintain high health standards at
low cost.
Japan’s medical security system is characterized by its
provisions for universal medical care, nursing care for
the elderly, and payment of health care expenses
In Japan, patients pay an insurance premium that is
linked to their normal level of income. They also con-
Abstract
The health insurance system in Japan is based upon the
Universal Medical Care Insurance System, which gives
all citizens the right to join an insurance scheme of their
own choice, as guaranteed by the provisions of Article
25 of the Constitution of Japan, which states: “All
people shall have the right to maintain the minimum
standards of wholesome and cultured living.” The
health care system in Japan includes national medical
insurance, nursing care for the elderly, and government
payments for the treatment of intractable diseases.
Medical insurance provisions are handled by
Employee’s Health Insurance (Social Insurance), which
mainly covers employees of private companies and their
families, and by National Health Insurance, which
provides for the needs of self-employed people. Both
schemes have their own medical care service programs
for retired persons and their families. The health care
system for the elderly covers people 75 years of age and
over and bedridden people 65 years of age and over.
There is also a system under which the government pays
all or part of medical expenses, and/or pays medical
expenses not covered by insurance. This is referred to
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tribute toward the cost of treatment when they receive
medical care. A substantial part of the cost of medical
treatment is paid for either by their employers or by
national and local governments from their ﬁnancial
resources (tax revenues). The amount of the premium is
determined by the person’s income at the time the
medical service is provided, and the cost of his or her
medical treatment is fully covered, irrespective of the
amount of the premium the person has paid. The big-
gest difference between this system and private insur-
ance schemes is that the resources of the latter come
entirely from the premiums paid by policyholders.
Japan’s medical insurance system originated with the
Health Insurance Law, which was enacted in 1922. Ar-
ticle 25 of the new Constitution of Japan, promulgated
in 1946 after the end of the Second World War, stipu-
lates: “All people shall have the right to maintain the
minimum standards of wholesome and cultured living.”
It also states: “In all spheres of life, the State shall use its
endeavors for the promotion and extension of social
welfare and security, and of public health.” The social
security system is based on the Constitution, and the
provisions for universal medical care insurance were
completed in 1961. Currently, subscribers themselves
and their families must pay 30% of medical care costs
and the elderly must pay 10% to 20%.
In broad terms, Japan’s health care system is respon-
sible for (1) medical insurance, (2) healthcare for the
elderly, and (3) government payments for medical
care. Medical insurance is provided for by Employee’s
Health Insurance (Social Insurance), which mainly
covers the employees of private companies and their
families, and by National Health Insurance, which pro-
vides for the needs of self-employed people. Both
schemes have their own medical care service programs
for retired persons and their families. The health
care system for the elderly is for people 75 years of age
and over and for bedridden people 65 years of age and
over.
The medical treatment payment system applicable to
patients with severe acute pancreatitis
There is also a system under which the government pays
all or part of the medical expenses and/or medical
expenses not covered by insurance. This system is re-
ferred to collectively as the “medical expenses payment
system”.
The purpose of the medical expenses payment system
is to improve and develop social welfare and public
health. The system is funded by national and local gov-
ernments from their normal ﬁnancial resources (e.g., tax
revenues). This system provides for a range of services,
such as medical aid based on the Livelihood Protection
Law; medical allowances based on the Child Welfare
Law, the Maternal and Child Health Law, the Tubercu-
losis Control Law, and the Law Related to Mental
Health and Welfare; medical care services for those
certiﬁed as atomic bomb victims; beneﬁts under the
Law for Aid to Wounded and Sick-Retired Soldiers;
and medical aid for speciﬁed intractable diseases, in-
cluding severe acute pancreatitis.
Medical aid for speciﬁed diseases
In 1973, medical aid for speciﬁed diseases — namely,
the medical treatment cost payment system — was
launched by the Ministry of Health, Labour, and Wel-
fare as a measure to reduce mortality caused by intrac-
table diseases. It is designed to reduce the cost of
medical treatment to be borne by patients with severe
and/or rare intractable diseases (45 such conditions are
currently speciﬁed). Severe acute pancreatitis is one of
the speciﬁed diseases, and the entire cost of the medical
treatment for these speciﬁed diseases is recovered from
public funds from the date when the application for a
certiﬁcate to receive treatment for a speciﬁed disease is
ﬁled.
The patients themselves, or their families, apply for
payment to their local health center or prefectural gov-
ernment (depending on where they live) by submitting
(1) an application form for a certiﬁcate to receive treat-
ment for a speciﬁed disease, (2) a certiﬁcate of resi-
dence, and (3) a clinical examination record prepared
by their medical practitioner. Once it has been proven
that a person has a speciﬁc disease, the cost of medical
treatment paid by the patient under the terms of the
standard medical insurance scheme will, in principle, be
borne by the national and local (prefectural) govern-
ments (on a 50%-50% basis) for a period of 6 months
(or longer, if the severe acute pancreatitis continues)
from the date of the application for payment. Because
the medical treatment costs are paid for only after
the date of application, this application should be
made as quickly as possible. It should be noted that,
under this system, the deﬁnition of severe acute pancre-
atitis is as speciﬁed by the severity assessment criteria
established by the Ministry of Health, Labour, and
Welfare.
The homepage website of the Japan Intractable
Disease Center (http://www.nanbyou.or.jp) provides
patients with severe acute pancreatitis and their families
with information on subjects such as the “Severity
Assessment Criteria”1,2 and the “Clinical Examination
Record.” The information has been prepared by the
Research Group for Speciﬁc Intractable Pancreatic
Diseases, which is sponsored by the Japanese Ministry
of Health, Labour, and Welfare.M. Yoshida et al.: Insurance system for acute pancreatitis in Japan 9
Comparisons between Western health insurance
systems and the Japanese system
United States
Medical insurance in the United States is primarily pro-
vided by private insurance companies. As of 2004, there
were 44 million people in the United States without
health care insurance.3  Wealthy people are able to
obtain very advanced, but expensive, medical care ser-
vices, whereas the uninsured poor can only afford some
of the medical services available.
Many insurance companies, whose operations are
principally inﬂuenced by the critical issue of how medi-
cal expenses should be paid, have introduced “managed
care” and “medical management guidelines” in an at-
tempt to standardize medical management procedures.
Moreover, some insurers endeavor to limit medical ex-
pense payments by introducing “gatekeeper” systems,4
under which patients can receive medical services from
a specialist physician only after being referred by their
primary care physicians.
Germany
In Germany, patients can freely choose their general
practitioner, but they cannot change their practitioner
for at least 3 months after the ﬁrst visit, unless there is a
special reason for so doing. Access to a hospital special-
ist is subject to referral by their primary care physician
and often takes a very long time. If patients consult a
specialist without being referred, they must pay the cost
of medical treatment.
Under the pressure of health care reform in Germany
in the 1990s, interactions among the state, medical in-
surance funds, and providers are said to have entered a
new era.5
United Kingdom
Access to physicians and medical institutions in the
United Kingdom is via a registration system.6 Everyone
must register with a general practitioner and, except in
emergencies, patients are referred to a hospital after
ﬁrst being examined by that physician. However, be-
cause of a severe medical cost-control program imposed
by the government, clinical care units are facing rapid
increases in the lengths of their waiting lists.
Conclusion
It is fair to say that Japan’s primary care system, which
enables patients to receive treatment at advanced spe-
cialist medical institutions from the very outset, is very
unusual. This is extremely beneﬁcial for patients with
severe acute pancreatitis, who require treatment with
minimal delay.
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